[The value of the granulocyte phagocytic test in oncology follow-up care].
This work represents the results of the granulocyte phagocytic test in tumor effected individuals by observing the course over a period up to three years. In tumor patients, which could be operated radically, a normal phagocytosis activity of granulocytes indicates the undisturbed course. In patients with progressive carcinoma growth the average of phagocytosis is lowered obviously. These results revealed information for the prognosis of malignant diseases and the nonspecific accompanying diseases.
D000230:Adenocarcinoma / Q000503:physiopathology; D000368:Aged; D001943:Breast Neoplasms / Q000503:physiopathology; D005260:Female; D005500:Follow-Up Studies; D006098:Granulocytes / Q000502:physiology*; D006801:Humans; D007680:Kidney Neoplasms / Q000503:physiopathology; D008297:Male; D009369:Neoplasms / Q000503:physiopathology* / Q000601:surgery; D010587:Phagocytosis; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000503:physiopathology; D012004:Rectal Neoplasms / Q000503:physiopathology
Zum Wert des Granulozytenphagozytosetests in der onkologischen Nachsorge.